These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31685398)

  • 21. Same Game, Different Players: Emerging Pathogens of the CF Lung.
    Gannon AD; Darch SE
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
    Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
    Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic fibrosis: a polymicrobial infectious disease.
    Sibley CD; Rabin H; Surette MG
    Future Microbiol; 2006 Jun; 1(1):53-61. PubMed ID: 17661685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymicrobial-Host Interactions during Infection.
    Tay WH; Chong KK; Kline KA
    J Mol Biol; 2016 Aug; 428(17):3355-71. PubMed ID: 27170548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy.
    Lopes SP; Azevedo NF; Pereira MO
    Crit Rev Microbiol; 2015; 41(3):353-65. PubMed ID: 24645634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial host interactions in cystic fibrosis.
    Callaghan M; McClean S
    Curr Opin Microbiol; 2012 Feb; 15(1):71-7. PubMed ID: 22137884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
    Rogers GB; Hoffman LR; Whiteley M; Daniels TW; Carroll MP; Bruce KD
    Trends Microbiol; 2010 Aug; 18(8):357-64. PubMed ID: 20554204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial ecology of the cystic fibrosis lung.
    Harrison F
    Microbiology (Reading); 2007 Apr; 153(Pt 4):917-923. PubMed ID: 17379702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.
    Caverly LJ; Zhao J; LiPuma JJ
    Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S31-8. PubMed ID: 26335953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current concepts: host-pathogen interactions in cystic fibrosis airways disease.
    Tang AC; Turvey SE; Alves MP; Regamey N; Tümmler B; Hartl D
    Eur Respir Rev; 2014 Sep; 23(133):320-32. PubMed ID: 25176968
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Model Systems to Study the Chronic, Polymicrobial Infections in Cystic Fibrosis: Current Approaches and Exploring Future Directions.
    O'Toole GA; Crabbé A; Kümmerli R; LiPuma JJ; Bomberger JM; Davies JC; Limoli D; Phelan VV; Bliska JB; DePas WH; Dietrich LE; Hampton TH; Hunter R; Khursigara CM; Price-Whelan A; Ashare A; Cramer RA; Goldberg JB; Harrison F; Hogan DA; Henson MA; Madden DR; Mayers JR; Nadell C; Newman D; Prince A; Rivett DW; Schwartzman JD; Schultz D; Sheppard DC; Smyth AR; Spero MA; Stanton BA; Turner PE; van der Gast C; Whelan FJ; Whitaker R; Whiteson K
    mBio; 2021 Oct; 12(5):e0176321. PubMed ID: 34544277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review.
    Somayaji R; Parkins MD; Shah A; Martiniano SL; Tunney MM; Kahle JS; Waters VJ; Elborn JS; Bell SC; Flume PA; VanDevanter DR;
    J Cyst Fibros; 2019 Mar; 18(2):236-243. PubMed ID: 30709744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering the role of phage in the cystic fibrosis airway.
    Willner D; Furlan M
    Virulence; 2010; 1(4):309-13. PubMed ID: 21178461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of the respiratory tract microbiota in cystic fibrosis.
    de Koff EM; de Winter – de Groot KM; Bogaert D
    Curr Opin Pulm Med; 2016 Nov; 22(6):623-8. PubMed ID: 27583669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate immune functions of the airway epithelium.
    Bartlett JA; Fischer AJ; McCray PBJ
    Contrib Microbiol; 2008; 15():147-163. PubMed ID: 18511860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of the respiratory tract microbiota in cystic fibrosis.
    de Koff EM; Groot KM; Bogaert D
    Curr Opin Pulm Med; 2016 Nov; 22(6):623-628. PubMed ID: 27841789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways.
    Khanolkar RA; Clark ST; Wang PW; Hwang DM; Yau YCW; Waters VJ; Guttman DS
    mSystems; 2020 Dec; 5(6):. PubMed ID: 33262240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.